Jonsson Comprehensive Cancer Center: Glioma trials
The registry lists 12 Glioma studies with Jonsson Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 8Phase 2 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsRecruitingNCT06650163Phase 1
- Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT01635283Phase 2Results posted
- Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutantWithdrawnNCT05457959Phase 1
- Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent GliomaActive, not recruitingNCT05045027Early Phase 1
- Dendritic Cell Vaccine for Patients With Brain TumorsCompletedNCT01204684Phase 2
- Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaCompletedNCT00107185Phase 1
- Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedNCT00087061Phase 1/2
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00068510Phase 1
- Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaCompletedNCT00005082Not applicable